New York, NY · Founded 2016 · Privately Held (backing)
Developer of an intra-operative nerve visualization technology intended to reduce the risk of nerve damage. Illuminare Biotechnologies is based in New York, NY and was founded in 2016. Its last reported valuation was $11.4 million in Aug 2017. It has raised $7.1 million across 1 recorded round; the latest was a $3.6 million seed round in May 2026.
Last reported valuation
$11.4M
Oct 2026
Priced at
—
Total raised
$7.1M
Last round
Seed Round
May 2026
Team — not yet on record
No current team members for Illuminare Biotechnologies are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Illuminare Biotechnologies with a free account
·Watch Illuminare Biotechnologies: the Monday email on marks, rounds and moves
